Skip to content

Food Intake and Thermogenesis in High Spinal Cord Injury

Food Intake and Thermogenesis in High Spinal Cord Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07103993
Enrollment
56
Registered
2025-08-05
Start date
2026-03-13
Completion date
2027-12-31
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCI - Spinal Cord Injury

Brief summary

The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

Interventions

OTHERLow meal condition

Participants will consume a standardized meal (500 grams) with a low nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours

OTHERModerate meal condition

Participants will consume a standardized meal (500 grams) with a moderate nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours.

OTHERHigh meal condition

Participants will consume a standardized meal (500 grams) with a high nutrient modification one time at one visit. Participants will attend one visit per week for 3 weeks. Each is visit separated by one week and each visit will take approximately 6 hours.

The ad-libitum meal consists of 600-700 g of a standardized control meal one time at all visits. Participants will attend one visit per week for 3 weeks. Each visit is separated by one week and each visit will take approximately 6 hours.

Sponsors

University of Miami
Lead SponsorOTHER
The Craig H. Neilsen Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

SCI and Controls * Men * Physically inactive (\<150 minutes per week of moderate-vigorous activity intensity for the preceding 3 months) * Weight stable: body mass ±3 kilograms (kg) for past 3 months SCI Only * Chronic SCI (≥ 1-year post-injury) * Motor-complete SCI American Spinal Injury Association Impairment Scale (AIS) A and B * T6 injuries and above that can independently feed themselves

Exclusion criteria

SCI and Controls * Uncompensated thyroid disease * Diabetes * Swallowing or gastrointestinal pathologies * Allergies or aversions to foods/ingredients * Prescribed prokinetic, antipsychotic, or anti-obesity agents SCI Only * Incomplete SCI AIS C or D * Ventilator-dependent

Design outcomes

Primary

MeasureTime frameDescription
Diet induced thermogenesis (DIT)up to 3 weeks (collected during each of the intervention visits)Diet-induced thermogenesis (DIT) will be measured using indirect calorimetry. A portable mask-based metabolic system, which will measure expired air to calculate dietary-induced thermogenesis defined as the energy expended above resting and the proportion of meal energy expended postprandially (postprandial kilocalorie (kcal) expended/total meal kcal) where a higher value means more energy is expended.
Hunger Series Visual Analog Scaleup to 3 weeks (collected during each of the intervention visits)Satiety will be measured using the Hunger Series Visual Analog Scale (HSVAS), which assesses subjective appetite. Each scale is defined at 0 as "not at all hungry" and 100 as "totally/a lot/very hungry". A sum score will be calculated.
Post ad-libitum energy intake measured in gramsup to 3 weeks (collected during each of the intervention visits)This value will be expressed as a ratio of energy consumed to energy requirements (energy intake/energy requirements x 100) and will be recorded in grams.

Countries

United States

Contacts

CONTACTGuillermo Mederos
gxm1228@med.miami.edu(305) 243-4518
CONTACTGary J Farkas, PhD
gjf50@med.miami.edu(305) 243-4518
PRINCIPAL_INVESTIGATORGary J Farkas, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026